Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 175,738,382
- Total 13F value
- $947,161,661
- Share change
- +1,575,779
- Put/Call ratio
- 95%
- SEC-reported price per share
- $5.39
- Number of holders
- 217
- Value change
- -$12,647,310
- Number of buys
- 119
- Number of sells
- 98
- Shares outstanding
- 29,109,163
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
217
Top holders
10
NKTR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Ownership snapshot
Top reported holders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invesco Ltd.
Disclosed value leader
Invesco Ltd.
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 127%
Showing 1-6 of 15 holder rows.
Quick read
Invesco Ltd. leads the comparable SEC ownership view at 127%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invesco Ltd.'s linked filing trail.
Comparable ownership
Top 5
Invesco Ltd.
127%
BlackRock Finance, Inc.
92%
VANGUARD GROUP INC
64%
PRIMECAP MANAGEMENT CO/CA/
60%
WELLINGTON MANAGEMENT GROUP LLP
39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invesco Ltd. |
13F
Company
|
127%
|
$498,405,000
36,891,494 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
92%
|
$360,336,000
26,671,803 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
64%
|
$250,095,000
18,511,911 shares
|
— | 31 Dec 2021 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
60%
|
$235,242,000
17,412,422 shares
|
— | 31 Dec 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
39%
|
$153,794,000
11,383,721 shares
|
— | 31 Dec 2021 |
| FMR LLC |
13F
Company
|
23%
|
$91,317,000
6,759,204 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
217
Shares
175,738,382
Rows available
217
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2026 Across Filers
Q1 2026 holders
7
Q1 2022 holders
217
Holder diff
210
| Investor | Q1 2026 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend